Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN\SUMATRIPTAN vs NATAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN\SUMATRIPTAN vs NATAMYCIN: Safety Overview

Metric NAPROXEN\SUMATRIPTAN NATAMYCIN
Total FAERS Reports 233 258
Deaths Reported 15 61
Death Rate 6.4% 23.6%
Hospitalizations 14 101
Average Patient Age 47.8 yrs 57.9 yrs
% Female Patients 84.5% 50.0%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Harrow Eye, LLC
Route N/A OPHTHALMIC
Marketing Status N/A Prescription